Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2009
10/29/2009CA2720677A1 Compositions and methods to enhance the immune system
10/28/2009EP2112225A1 Recombinant pox virus for immunization against tumor-associated antigens
10/28/2009EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/28/2009EP2112167A2 Humanized ANTI-ERBB2 antibodies and treatment with ANTI-ERBB2 antibodies
10/28/2009EP2112166A2 Human monoclonal antibodies to CTLA-4
10/28/2009EP2112159A2 Immuno-interactive fragments of the alpha C subunit of inhibin
10/28/2009EP2112154A1 Esters in position 20 of camptothecins
10/28/2009EP2112152A1 Dihydropteridinones as Plk Inhibitors
10/28/2009EP2112150A1 Improved raf inhibitors
10/28/2009EP2112148A1 Solid salt forms of a pyrrole substituted 2-indolinone
10/28/2009EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009EP2111870A1 Dosages for treatment of anti-erbB2 antibodies
10/28/2009EP2111869A1 Compositions and methods to enhance the immune system
10/28/2009EP2111867A1 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
10/28/2009EP2111825A1 Catheter balloon systems and balloon with herniation
10/28/2009EP2111409A1 Novel cationic 17 alpha- substituted-estradiol derivatives useful as anti-cancer agent
10/28/2009EP2111403A1 Triazabenzo[e]azulene derivatives for the treatment of tumors
10/28/2009EP2111402A2 Aminopyrazole kinase inhibitors
10/28/2009EP2111401A1 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino]-3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009EP2111235A1 A method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging
10/28/2009EP2111231A2 Methods and compositions for improving immune responses
10/28/2009EP2111229A2 Activin-actriia antagonists and uses for treating or preventing breast cancer
10/28/2009EP2111228A2 Vegf pathway blockade
10/28/2009EP1850830B1 Suppository for binding of reactive oxygen compounds in human and animal bodies
10/28/2009EP1786779B1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
10/28/2009EP1696914B1 3-cyano-quinoline derivatives with antiproliferative activity
10/28/2009EP1548032B9 Kdr peptides and vaccines comprising the same
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1497438B1 Means and methods for the production of adenovirus vectors
10/28/2009EP1436003B1 Taci-immunoglobulin fusion proteins
10/28/2009EP1404323B1 Use of methylnaltrexone to treat immune suppression
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1181047B2 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
10/28/2009EP1128731B1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
10/28/2009EP1012232B1 Genetically modified tumor-targeted bacteria with reduced virulence
10/28/2009CN101568550A Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
10/28/2009CN101568544A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith
10/28/2009CN101568539A Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
10/28/2009CN101568530A Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors
10/28/2009CN101568521A Inhibitors of zinc proteases thioaryl substituted and their use
10/28/2009CN101568343A Methods for treating cancer
10/28/2009CN101568342A Treatment for multiple myeloma
10/28/2009CN101568338A Novel therapeutic use for treating leukaemia
10/28/2009CN101568337A Combination of mek inhibitor and the src kinase inhibitor azd0530 for use in the treatment of cancer
10/28/2009CN101568332A Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
10/28/2009CN101565858A Composition containing peptide binding domain and method for forming nanoparticles and nanowires therefrom
10/28/2009CN101565718A Construction method of three-target mosaic type oncolytic adenovirus Ad5/F11 carrier and use thereof
10/28/2009CN101565692A Construction and application of multiple target-point anti-cancer adenoviruses
10/28/2009CN101565446A Veratramine degradation product veratrum fluorene aldehyde and the derivatives thereof, as well as the preparation and application thereof
10/28/2009CN101565445A Method for preparing high-purity veratramine and jervine
10/28/2009CN101565443A New fir triterpene lactone compound, preparation method and application thereof
10/28/2009CN101565413A Isoflavone derivative modified by acetylaminoacid benzyl ester, preparation method and application thereof
10/28/2009CN101565411A Method for extracting fucoxanthin from brown algae
10/28/2009CN101565402A Indeno isoquinolone compound and preparation method and medical application thereof
10/28/2009CN101564539A Chitosan oligosaccharide fatty acid grafting-adriamycin bonded drug, preparation and applications
10/28/2009CN101564535A Cancer treatment method
10/28/2009CN101564527A Chinese medicament and western medicament combined formulation for treating cancerous diarrhea and processing method thereof
10/28/2009CN101564469A Lycium barbarum polysaccharide extract and pharmaceutical application thereof
10/28/2009CN101564466A Traditional Chinese medicine effective part composition containing antineoplastic active ingredients as well as preparation method and application thereof
10/28/2009CN101564440A Anti-aging preparation
10/28/2009CN101564415A Chinese medicine microemulsion preparation with enhanced percutaneous permeability and preparation method thereof
10/28/2009CN101564414A Western bovine bezoar preparation and preparation method thereof
10/28/2009CN101564411A Method for extracting anti-tumor medicine from single southernwood extraction
10/28/2009CN101564410A Method for extracting anti-tumor active substance from common cephalanoplos herb and common cephalanoplos herb anti-tumor medicament
10/28/2009CN101564393A Novel application of nitidine
10/28/2009CN101564392A Novel application of sanguinarine
10/28/2009CN101564391A Usage of oxidized aporphine derivative and composition thereof
10/28/2009CN101564390A Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
10/28/2009CN101564388A Composition for Danshensu and danshinolic acid B and use thereof
10/28/2009CN101564381A Gemcitabine hydrochloride lyophilized powder injection
10/28/2009CN100554425C Deletion mutant of a set of hepatitis B HBx gene and application thereof
10/28/2009CN100554326C Immune polysaccharide of rhizome of manyflower solomonseal, composition and application
10/28/2009CN100554278C Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit
10/28/2009CN100554273C Derivative of organic phosphorus of containing structure of spirocyclic / cyclopropane, preparation method and application
10/28/2009CN100554270C Method for preparing dehydrogenated cavidine, dehydrogenated apocavidine and combination
10/28/2009CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/28/2009CN100554265C N-(4-bromo-2- fluorobenzene)-6-methox-7-[2(1H-1,2,3-1- triazole) ethoxy]-4-quinazoline amine hydrochloric acid synthesis and uses
10/28/2009CN100554226C Preparation method of estrogen activity-possessed red clover extractive
10/28/2009CN100553682C G type non-viral vector and pharmaceutical composition containing same
10/28/2009CN100553675C Process of preparing calcitonin microsphere
10/28/2009CN100553638C Application of alisol B23-mono acetic ester and alisma rhizome extract in reversal of cancer cell multi-drug tolerance
10/28/2009CN100553634C Epothilone derivatives for the treatment of multiple myeloma
10/28/2009CN100553629C Pharmaceutical use of paeonol for anti-esophageal cancer
10/28/2009CN100553628C Use of 2-bromo-isovanillin in preparing anti-cancer and/or anti-radiation, chemical therapy sensitivity-enhancing medicines
10/28/2009CN100553623C Chinese caterpillar fungus formulation preparation method
10/28/2009CN100553612C Preparing process of nano c-FLIP antisense oligonucleotide particle
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
10/27/2009US7608687 Releasable linkage and compositions containing same
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608628 Alkylsulphonamide quinolines
10/27/2009US7608624 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
10/27/2009US7608623 N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine-4-ethoxycarbonylpiperazinium hydrogen sulfate; N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyguanidino-(L)-phenylalanine-4-ethoxycarbonylpiperazide; urokinase plasminogen activator inhibitor; anticarcinogenic agent
10/27/2009US7608620 inhibitors of lysophosphatidic acid acyltransferase beta (LPAAT- beta ) activity; cancer screening therapy
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608615 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof
10/27/2009US7608582 Channel protein modified with a pH-responsive or light-responsive compound, coupling group C in combination with either a chargeable group or with a photocleavable chargeable group
1 ... 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 ... 2211